Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
305 College Road East, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
MedaSorb Technologies CORP (to 4/15/2010), GILDER ENTERPRISES INC (to 7/24/2006)
Latest financial report
Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 180 % -27%
Quick Ratio 32.1 % +33.4%
Debt-to-equity 180 % +69.4%
Return On Equity -104 % -18.4%
Return On Assets -37.1 % +12.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.7M shares +23%
Common Stock, Shares, Outstanding 54.5M shares +24.3%
Entity Public Float 144M USD
Common Stock, Value, Issued 54.5K USD +22.6%
Weighted Average Number of Shares Outstanding, Basic 54.5M shares +22.7%
Weighted Average Number of Shares Outstanding, Diluted 54.5M shares +22.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.72M USD -35.4%
Operating Income (Loss) -22.1M USD +21.3%
Nonoperating Income (Expense) 2.67M USD -26.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.5M USD +20.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -18.7M USD +20.3%
Earnings Per Share, Basic -0.36 USD/shares +33.3%
Earnings Per Share, Diluted -0.36 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.69M USD -32%
Accounts Receivable, after Allowance for Credit Loss, Current 6.63M USD +7.35%
Inventory, Net 3.25M USD +9.09%
Assets, Current 16.6M USD -13.8%
Property, Plant and Equipment, Net 9.27M USD -9.85%
Operating Lease, Right-of-Use Asset 11.7M USD -4.46%
Other Assets, Noncurrent 3.8M USD -8.38%
Assets 47.8M USD +0.48%
Accounts Payable, Current 2.34M USD -32.1%
Accrued Liabilities, Current 498K USD -41.5%
Contract with Customer, Liability, Current 1.38M USD -8.96%
Liabilities, Current 8.43M USD -29.6%
Operating Lease, Liability, Noncurrent 12.6M USD -2.51%
Liabilities 34.8M USD +19.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -157K USD -105%
Retained Earnings (Accumulated Deficit) -295M USD -6.75%
Stockholders' Equity Attributable to Parent 13M USD -29.8%
Liabilities and Equity 47.8M USD +0.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.83M USD -55.4%
Net Cash Provided by (Used in) Financing Activities -572K USD -184%
Net Cash Provided by (Used in) Investing Activities -127K USD +81.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 54.5M shares +22.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.52M USD -78.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2M USD +21.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 199K USD +180%
Deferred Tax Assets, Valuation Allowance 45.3M USD +15.3%
Deferred Tax Assets, Gross 49M USD +13.7%
Operating Lease, Liability 13M USD -0.07%
Payments to Acquire Property, Plant, and Equipment 45.2K USD -91.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.8M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid 22.9M USD -5.36%
Property, Plant and Equipment, Gross 13.1M USD +3.58%
Operating Lease, Liability, Current 432K USD +269%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.69M USD +30.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.86M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.77M USD +2.37%
Deferred Tax Assets, Operating Loss Carryforwards 36.8M USD +16.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.81M USD +2.38%
Operating Lease, Payments 2.34M USD -10.5%
Additional Paid in Capital 308M USD +5.58%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.71M USD -3.27%
Share-based Payment Arrangement, Expense 3.19M USD -5.03%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%